Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
02/1999
02/17/1999EP0896821A1 A novel pharmaceutical composition for inhalation containing CR 2039 (andolast)
02/17/1999EP0896621A2 Cftr gene regulator
02/17/1999EP0896580A1 Specific immunophilin ligands as antiasthmatics and immunosuppressants
02/17/1999EP0896543A1 Drug for the treatment of tumours
02/17/1999EP0896537A1 Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl)-anilide and n-(4-trifluoromethylphenyl)2-cyano-3-hydroxycrotonic acid amide
02/17/1999EP0896525A1 Methods of dry powder inhalation
02/17/1999CN1208418A Pyrido-1,2,4-thiadiazine and pyrido-1,4-thiazine derivatives, their preparation and use
02/17/1999CN1208417A Fused 1,2,4-thiadiazine and fused 1,4-thiazine derivatives, their preparation and use
02/17/1999CN1208412A Antagonists of gonadotropin releasing hormone
02/17/1999CN1208411A Benzofuran carboxamides and sulphonamides
02/17/1999CN1208403A Compounds
02/17/1999CN1208035A Dithiolan derivatives, their preparation and their therapeutic effect
02/17/1999CN1208034A Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
02/17/1999CN1207929A Baizhong plaster for children
02/17/1999CN1207915A Application of theachrome in preparing medicine for pulmonitis
02/16/1999US5872280 Respiratory system disorders
02/16/1999US5872140 Vitamin D analogues
02/16/1999US5871771 Micronized biodegradable particles, process for preparing them and use thereof
02/15/1999CA2224096A1 The g-protein coupled receptor hfia041
02/13/1999CA2240627A1 Novel ratc
02/13/1999CA2240623A1 Novel rata
02/12/1999CA2239835A1 Human sdr2 cdna clone
02/12/1999CA2239819A1 Ftsz
02/11/1999WO1999006436A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006434A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006433A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006432A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006431A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006426A1 Novel molecules of the tango-77 related protein family and uses thereof
02/11/1999WO1999006423A1 83 human secreted proteins
02/11/1999WO1999006404A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
02/11/1999WO1999006391A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
02/11/1999WO1999006390A1 Carbamyloxy compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999WO1999006354A1 Il-8 receptor antagonists
02/11/1999WO1999006340A2 Sulfonylamino substituted hydroxamic acid derivatives as metalloprotease inhibitors
02/11/1999WO1999006053A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators
02/11/1999WO1999006041A1 SUBSTITUTED ALKANOHYDROXAMIC ACIDS AND METHOD OF REDUCING TNFα LEVELS
02/11/1999WO1999006025A1 Method and compositions for treating late phase allergic reactions and inflammatory diseases
02/11/1999CA2299055A1 Novel molecules of the tango-77 related protein family and uses thereof
02/11/1999CA2298935A1 1,2,4-triazolo[4,3-b]pyrido[3,2-d]pyridazine derivatives and pharmaceutical compositions containing them
02/11/1999CA2298852A1 83 human secreted proteins
02/11/1999CA2298617A1 Acyclic metalloprotease inhibitors
02/11/1999CA2296485A1 N6-substituted-adenosine-5'-uronamides as adenosine receptor modulators
02/11/1999CA2295295A1 Substituted alkanohydroxamic acids and method of reducing tnf.alpha. levels
02/11/1999CA2294064A1 Il-8 receptor antagonists
02/11/1999CA2291473A1 Benzyl compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999CA2290750A1 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999CA2290749A1 Dipeptide and related compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999CA2290747A1 Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999CA2290746A1 Compounds which inhibit leukocyte adhesion mediated by vla-4
02/11/1999CA2239836A1 Novel arginine deiminase
02/11/1999CA2239813A1 Novel nrdd
02/11/1999CA2239221A1 Novel his5
02/10/1999EP0895780A1 Extended release tablets particularly containing pseudoephedrine hydrochloride
02/10/1999EP0710239B1 Novel 9-n-bicyclic nucleoside agents useful as selective inhibitors of proinflammatory cytokines
02/10/1999CN1207743A Inhibitors of interleukin-1 'beta' converting enzyme
02/10/1999CN1207730A Quinoline derivs.
02/10/1999CN1207686A FC 'epsilon'-PE chimeric protein for targeted treatment of allergy responses, method for its production and pharmaceutical compositions contg. same
02/10/1999CN1042030C Method for preparing substituted dibenzofurans
02/10/1999CN1042026C 25 carboxylic deriv. of vitamin D series, its preparing method, middle products in production of same and medicine contg. same and pharmaceutical use of same in treatment
02/09/1999US5869663 Intermediates for neurokinin receptor antagonists
02/09/1999US5869515 1,3-dihydro-2H-imidazol-2-one compounds
02/09/1999US5869511 Isoxazoline compounds as inhibitors of TNF release
02/09/1999US5869499 Benzyloxyquinuclidines as substance P antagonists
02/09/1999US5869496 Treating asthma, emesis
02/09/1999US5869492 Condensed thiazole derivatives, having 5-HT receptor affinity
02/09/1999US5869486 Fused pyrimidines and pyriazines as pharmaceutical compounds
02/09/1999US5869455 Serine protease inhibitors-N-substituted derivatives
02/09/1999US5869271 G-beta-gamma regulated phosphatidylinositol-3' kinase
02/09/1999CA2226091C Cyclosporin-containing soft capsule preparations
02/05/1999CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses
02/05/1999CA2239270A1 Novel phosphoribosyl transferase
02/05/1999CA2238673A1 Novel aminopeptidase
02/04/1999WO1999005155A2 Salts of di(uridine 5'-tetraphosphate), method for preparation and uses thereof
02/04/1999WO1999005144A1 Novel compounds
02/04/1999WO1999005143A1 Novel compounds
02/04/1999WO1999005142A1 Novel compounds
02/04/1999WO1999005132A1 Benzothia(oxa)diazol derivatives and their use as endothelin-receptor antagonists
02/04/1999WO1999005113A1 Substituted 6-phenylphenanthridines
02/04/1999WO1999005112A1 Substituted 6-alkylphenanthridines
02/04/1999WO1999005111A1 Novel tetrazole derivatives
02/04/1999WO1999005107A1 Vitronectin receptor antagonist
02/04/1999WO1999005095A1 Aminocycloalkane compounds
02/04/1999WO1999004794A1 Cyclic amine modulators of chemokine receptor activity
02/04/1999WO1999004791A1 A pharmaceutical composition active in reducing production of mcp-1 protein
02/04/1999WO1999004770A2 A pharmaceutical composition active in reducing production of mcp-1 protein
02/04/1999WO1999004765A2 Pharmaceutical compositions containing an effervescent acid-base couple
02/04/1999CA2298507A1 A pharmaceutical composition active in reducing production of mcp-1 protein
02/04/1999CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors
02/04/1999CA2297910A1 Vitronectin receptor antagonist
02/04/1999CA2297315A1 Endothelin receptor antagonists
02/04/1999CA2296648A1 Novel compounds
02/04/1999CA2296426A1 Novel compounds
02/04/1999CA2296329A1 Aminocycloalkane compounds
02/04/1999CA2296314A1 Cyclic amine modulators of chemokine receptor activity
02/03/1999EP0894862A2 Novel CysS
02/03/1999EP0894861A2 Glycogen phosphorylase from Streptococcus pneumoniae
02/03/1999EP0894856A1 A human sMAD3 splice variant
02/03/1999EP0894854A2 A novel splicing variant of the epstein-barr virus-induced g-protein coupled receptor
02/03/1999EP0894789A1 Substituted indole-2-carboxylic acids as glucosyl transferase inhibitors